Online Trial Tracker - Larvol Sigma

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

hydrocortisone / Generic mfg.

NCT00019409: Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia

Withdrawn

US, RoW

asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, therapeutic hydrocortisone, vincristine sulfate, radiation therapy

National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI)

Leukemia

07/01

NCT00002700: Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

Completed

392

Europe, RoW

asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, leucovorin calcium, mercaptopurine, methotrexate, mitoxantrone hydrochloride, prednisolone, prednisone, therapeutic hydrocortisone, vincristine sulfate, allogeneic bone marrow transplantation, autologous bone marrow transplantation, radiation therapy

European Organisation for Research and Treatment of Cancer - EORTC, Acute Leukemia French Association

Leukemia, Lymphoma

03/04

NCT00165178: Treatment of Acute Lymphoblastic Leukemia in Children

Completed

498

prednisone, dexamethasone, doxorubicin, dexrazoxane, E. coli asparaginase, vincristine, methotrexate, Leucovorin, Asparaginase, cytarabine, ARA-C, Methotrexate/Hydrocortisone

Dana-Farber Cancer Institute, Boston Children's Hospital, University of Rochester, McMaster University, San Jorge Children's Hospital (Puerto Rico), St. Justine's Hospital, Maine Children's Cancer Program, Ochsner Health System, Tulane University School of Medicine, Laval University, Columbia University

Acute Lymphoblastic Leukemia

12/04

05/11

NCT00002744: Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Completed

1970

US, Canada, RoW

asparaginase, L-Asparaginase - Erwinia, NSC-106977, cyclophosphamide, Cytoxan, NSC-26271., cytarabine, Cytosine Arabinoside, Ara-C, Cytosar-U, daunorubicin hydrochloride, NSC-82151, dexamethasone, Decadron, NSC-34521, doxorubicin hydrochloride, Adriamycin, NSC-123127, mercaptopurine, 6-MP, Purinethol, methotrexate, NSC-740, pegaspargase, PEG Asparaginase, Oncaspar®, prednisone, NSC-10023, therapeutic hydrocortisone, thioguanine, 6-TG, NSC-752, vincristine sulfate, Oncovin, NSC-67574, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy

Children's Oncology Group, National Cancer Institute (NCI)

Leukemia

03/07



	Diseases Companies Products Productz Mechanisms of Action Sites